StockData

Black Hawk Acquisition Corp (BKHA) stock

BKHANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends November 30Also trades as BKHAR, BKHAU
Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 6, 2026Score 5/30
$8.65+1.45 (+20.14%)

Close on Nov 17, 2026Market cap $35.93MP/E –Yield –

Earnings

Black Hawk Acquisition's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Black Hawk Acquisition's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Black Hawk Acquisition has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Black Hawk Acquisition puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Black Hawk Acquisition filed with the SEC as exhibits to Form 8-K or 6-K

See a number that looks wrong?